Alphaherpesviruses and chemokines: Pas de deux not yet brought to perfection

Journal of Virology

Volumn 82, Issue 13, 2008, Pages 6090-6097

  Van De Walle, Gerlinde R ^a   Jarosinski, Keith W ^a   Osterrieder, Nikolaus ^a,b  

^a Department of Obstetrics Gynecology   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHEMOKINE; FORMYLPEPTIDE RECEPTOR; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THROMBOSPONDIN;

BOVINE HERPES VIRUS; CHEMOTAXIS; CYTOTOXIC T LYMPHOCYTE; EQUINE HERPES VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; ILTOVIRUS; IMMUNOSURVEILLANCE; MARDIVIRUS; MOLECULAR EVOLUTION; MOLECULAR MIMICRY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PSEUDORABIES HERPETOVIRUS; SHORT SURVEY; VARICELLA ZOSTER VIRUS; VIRUS INTERFERENCE; VIRUS VIRULENCE;

ALPHAHERPESVIRINAE; CHEMOKINES; EVOLUTION, MOLECULAR; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 45749115801     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00098-08     Document Type: Short Survey

References (63)

1. Adamiak, B., M. Ekblad, T. Bergstrom, V. Ferro, and E. Trybala. 2007. Herpes simplex virus type 2 glycoprotein G is targeted by the sulfated oligoand polysaccharide inhibitors of virus attachment to cells. J. Virol. 81:13424-13434.
2. Alcami, A. 2003. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3:36-50.
3. Alcami, A. 2007. New insights into the subversion of the chemokine system by poxviruses. Eur. J. Immunol. 37:880-883.
4. Alcami, A., and U. H. Koszinowski. 2000. Viral mechanisms of immune evasion. Trends Microbiol. 8:410-418.
5. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565-568.
6. Balachandran, N., and L. M. Hutt-Fletcher. 1985. Synthesis and processing of glycoprotein gG of herpes simplex virus type 2. J. Virol. 54:825-832.
7. Balan, P., N. Davis-Poynter, S. Bell, H. Atkinson, H. Browne, and T. Minson. 1994. An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ. J. Gen. Virol. 75:1245-1258.
8. Baranowski, E., G. Keil, J. Lyaku, F. A. Rijsewijk, J. T. Van Oirschot, P. P. Pastoret, and E. Thiry. 1996. Structural and functional analysis of bovine herpesvirus 1 minor glycoproteins. Vet. Microbiol. 53:91-101.
9. Bellner, L., J. Karlsson, H. Fu, F. Boulay, C. Dahlgren, K. Eriksson, and A. Karlsson. 2007. A monocyte-specific peptide from herpes simplex virus type 2 glycoprotein G activates the NADPH-oxidase but not chemotaxis through a G-protein-coupled receptor distinct from the members of the formyl peptide receptor family. J. Immunol. 179:6080-6087.
10. Bellner, L., G. B. Lowhagen, P. Tunback, I. Nordstrom, J. A. Liljeqvist, and K. Eriksson. 2005. Characterization of T-cell reactive epitopes in glycoprotein G of herpes simplex virus type 2 using synthetic peptides. Arch. Virol. 150:1393-1406.
11. Bellner, L., F. Thoren, E. Nygren, J. A. Liljeqvist, A. Karlsson, and K. Eriksson. 2005. A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions. J. Immunol. 174:2235-2241.
12. Bennett, L. M., J. G. Timmins, D. R. Thomsen, and L. E. Post. 1986. The processing of pseudorabies virus glycoprotein gX in infected cells and in an uninfected cell line. Virology 155:707-715.
13. Biron, C. A. 2001. Interferons α and β as immune regulators - a new look. Immunity 14:661-664.
14. Bryant, N. A., N. Davis-Poynter, A. Vanderplasschen, and A. Alcami. 2003. Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. EMBO J. 22:833-846.
15. Cinamon, G., V. Grabovsky, E. Winter, S. Franitza, S. Feigelson, R. Shamri, O. Dwir, and R. Alon. 2001. Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow. J. Leukoc. Biol. 69:860-866.
16. Cinamon, G., V. Shinder, and R. Alon. 2001. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat. Immunol. 2:515-522.
17. Colle, C. F., III, C. C. Flowers, and D. J. O'Callaghan. 1992. Open reading frames encoding a protein kinase, homolog of glycoprotein gX of pseudorabies virus, and a novel glycoprotein map within the unique short segment of equine herpesvirus type 1. Virology 188:545-557.
18. Cortes, P. L., and C. J. Cardona. 2004. Pathogenesis of a Marek's disease virus mutant lacking vIL-8 in resistant and susceptible chickens. Avian Dis. 48:50-60.
19. Costes, B., M. B. Ruiz-Argüello, N. A. Bryant, A. Alcami, and A. Vanderplasschen. 2005. Both soluble and membrane-anchored forms of Felid herpesvirus 1 glycoprotein G function as a broad-spectrum chemokine-binding protein. J. Gen. Virol. 86:3209-3214.
20. Costes, B., M. Thirion, B. Dewals, J. Mast, M. Ackermann, N. Markine-Goriaynoff, L. Gillet, and A. Vanderplasschen. 2006. Felid herpesvirus 1 glycoprotein G is a structural protein that mediates the binding of chemokines on the viral envelope. Microbes Infect. 8:2657-2667.
21. Crabb, B. S., and M. J. Studdert. 1993. Epitopes of glycoprotein G of equine herpesviruses 4 and 1 located near the C termini elicit type-specific antibody responses in the natural host. J. Virol. 67:6332-6338.
22. Cui, X., L. F. Lee, W. M. Reed, H. J. Kung, and S. M. Reddy. 2004. Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency. J. Virol. 78:4753-4760.
23. Demmin, G. L., A. C. Clase, J. A. Randall, L. W. Enquist, and B. W. Banfield. 2001. Insertions in the gG gene of pseudorabies virus reduce expression of the upstream Us3 protein and inhibil cell-to-cell spread of virus infection. J. Virol. 75:10856-10869.
24. Devlin, J. M., G. F. Browning, C. A. Hartley, and J. R. Gilkerson. 2007. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine. Vaccine 25:3561-3566.
25. Devlin, J. M., G. F. Browning, C. A. Hartley, N. C. Kirkpatrick, A. Mahmoudian, A. H. Noormohammadi, and J. R. Gilkerson. 2006. Glycoprotein G is a virulence factor in infectious laryngotracheitis virus. J. Gen. Virol. 87:2839-2847.
26. Drummer, H. E., M. J. Studdert, and B. S. Crabb. 1998. Equine herpesvirus-4 glycoprotein G is secreted as a disulphide-linked homodimer and is present as two homodimeric species in the virion. J. Gen. Virol. 79:1205-1213.
27. Engelhardt, T., and G. M. Keil. 1996. Identification and characterization of the bovine herpesvirus 5 US4 gene and gene products. Virology 225:126-135.
28. Favoreel, H. W., G. R. Van de Walle, H. J. Nauwynck, and M. B. Pensaert. 2003. Virus complement evasion strategies. J. Gen. Virol. 84:1-15.
29. Guidotti, L. G., and F. V. Chisari. 2000. Cytokine-mediated control of viral infections. Virology 273:221-227.
30. Jarosinski, K. W., and K. A. Schat. 2007. Multiple alternative splicing to exons II and III of viral interleukin-8 (vIL-8) in the Marek's disease virus genome: the importance of vIL-8 exon I. Virus Genes 34:9-22.
31. Kaashoek, M. J., F. A. Rijsewijk, R. C. Ruuls, G. M. Keil, E. Thiry, P. P. Pastoret, and J. T. Van Oirschot. 1998. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene. Vaccine 16:802-809.
32. Karlin, S., E. S. Mocarski, and G. A. Schachtel. 1994. Molecular evolution of herpesviruses: genomic and protein sequence comparisons. J. Virol. 68:1886-1902.
33. S open reading frame 4 encodes a glycoproteoglycan. J. Virol. 70:3032-3038.
34. Kimman, T. G., N. de Wind, N. Oei-Lie, J. M. Pol, A. J. Berns, and A. L. Gielkens. 1992. Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity. J. Gen. Virol. 73:243-251.
35. Kongsuwan, K., M. A. Johnson, C. T. Prideaux, and M. Sheppard. 1993. Identification of an infectious laryngotracheitis virus gene encoding an immunogenic protein with a predicted M(r) of 32 kilodaltons. Virus Res. 29:125-140.
36. Lalani, A. S., J. W. Barrett, and G. McFadden. 2000. Modulating chemokines: more lessons from viruses. Immunol. Today 21:100-106.
37. Liu, J. L., S. F. Lin, L. Xia, P. Brunovskis, D. Li, I. Davidson, L. F. Lee, and H. J. Kung. 1999. MEQ and V-IL8: cellular genes in disguise? Acta Virol. 43:94-101.
38. Lubinski, J., T. Nagashunmugam, and H. M. Friedman. 1998. Viral interference with antibody and complement. Semin. Cell Dev. Biol. 9:329-337.
39. Lusso, P. 2000. Chemokines and viruses: the dearest enemies. Virology 273:228-240.
40. Martins-Green, M. 2001. The chicken chemotactic and angiogenic factor (cCAF), a CXC chemokine. Int. J. Biochem. Cell Biol. 33:427-432.
41. McFadden, G., A. Lalani, H. Everett, P. Nash, and X. Xu. 1998. Virus-encoded receptors for cytokines and chemokines. Semin. Cell Dev. Biol. 9:359-368.
42. McGeoch, D. J., F. J. Rixon, and A. J. Davison. 2006. Topics in herpesvirus genomics and evolution. Virus Res. 117:90-104.
43. Mettenleiter, T. C., B. G. Klupp, F. Weiland, and N. Visser. 1994. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine. J. Gen. Virol. 75:1723-1733.
44. Middleton, J., S. Neil, J. Wintle, I. Clark-Lewis, H. Moore, C. Lam, M. Auer, E. Hub, and A. Rot. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91:385-395.
45. Murphy, P. M. 1993. Molecular mimicry and the generation of host defense protein diversity. Cell 72:823-826.
46. Nakamichi, K., Y. Matsumoto, and H. Otsuka. 2002. Bovine herpesvirus 1 glycoprotein G is necessary for maintaining cell-to-cell junctional adherence among infected cells. Virology 294:22-30.
47. Nakamichi, K., K. Ohara, D. Kuroki, and H. Otsuka. 2000. Bovine herpesvirus 1 glycoprotein G is required for viral growth by cell-to-cell infection. Virus Res. 68:175-181.
48. Parcells, M. S., S. F. Lin, R. L. Dienglewicz, V. Majerciak, D. R. Robinson, H. C. Chen, Z. Wu, G. R. Dubyak, P. Brunovskis, H. D. Hunt, L. F. Lee, and H. J. Kung. 2001. Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J. Virol. 75:5159-5173.
49. Patel, J. R., and J. Heldens. 2005. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4) - epidemiology, disease and immunoprophylaxis: a brief review. Vet. J. 170:14-23.
50. Pellett, P. E., and B. Roizmann. 2007. Herpesviridae, p. 2479-2499. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
51. Richman, D. D., A. Buckmaster, S. Bell, C. Hodgman, and A. C. Minson. 1986. Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it. J. Virol. 57:647-655.
52. Schall, T. J., and K. B. Bacon. 1994. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6:865-873.
53. Seet, B. T., and G. McFadden. 2002. Viral chemokine-binding proteins. J. Leukoc. Biol. 72:24-34.
54. r cleavage product. J. Virol. 61:1735-1737.
55. Thomsen, D. R., C. C. Marchioli, R. J. Yancey, Jr., and L. E. Post. 1987. Replication and virulence of pseudorabies virus mutants lacking glycoprotein gX. J. Virol. 61:229-232.
56. Tortorella, D., B. E. Gewurz, M. H. Furman, D. J. Schust, and H. L. Ploegh. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18:861-926.
57. Tran, L. C., J. M. Kissner, L. E. Westerman, and A. E. Sears. 2000. A herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivo. Proc. Natl. Acad. Sci. USA 97:1818-1822.
58. Trapp, S., N. Osterrieder, G. M. Keil, and M. Beer. 2003. Mutagenesis of a bovine herpesvirus type 1 genome cloned as an infectious bacterial artificial chromosome: analysis of glycoprotein E and G double deletion mutants. J. Gen. Virol. 84:301-306.
59. Van de Walle, G. R., M. L. May, W. Sukhumavasi, J. von Einem, and N. Osterrieder. 2007. Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo. J. Immunol. 179:4161-4169.
60. Van de Walle, G. R., K. Sakamoto, and N. Osterrieder. 2008. CCL3 and viral chemokine-binding protein gG modulate pulmonary inflammation and virus replication during equine herpesvirus type 1 (EHV-1) infection. J. Virol. 82:1714-1722.
61. van Maanen, C. 2002. Equine herpesvirus 1 and 4 infections: an update. Vet. Q. 24:58-78.
62. von Einem, J., P. M. Smith, G. R. Van de Walle, D. J. O'Callaghan, and N. Osterrieder. 2007. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG). Virology 362:151-162.
63. Webb, L. M., and A. Alcami. 2005. Virally encoded chemokine binding proteins. Mini Rev. Med. Chem. 5:833-848.